Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Mar 16, 2016
Insider Transaction Report
Form 4
Harmon J Frank
EVP, Global Operations
Transactions
- Award
Common Stock
2016-03-14+8,915→ 8,915 total - Award
Stock Option to Buy
2016-03-14+18,897→ 18,897 totalExercise: $13.46Exp: 2026-03-14→ Common Stock (18,897 underlying)
Footnotes (1)
- [F1]The option vests in four equal installments beginning on March 14, 2017.